Improved long-term health-related quality of life after islet transplantation

Transplantation

Volumn 86, Issue 9, 2008, Pages 1161-1167

  Tharavanij, Thipaporn ^a,b   Betancourt, Arthur ^a   Messinger, Shari ^a   Cure, Pablo ^a   Leitao, Cristiane B ^a   Baidal, David A ^a   Froud, Tatiana ^a,c   Ricordi, Camillo ^a,c   Alejandro, Rodolfo ^a,c,d  

^a UNIVERSITY OF MIAMI   (United States)

^b THAMMASAT UNIVERSITY   (Thailand)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

Diabetes; Islet transplantation; Quality of life

Indexed keywords

INSULIN; ANTIDIABETIC AGENT; EXENDIN 4; PEPTIDE; VENOM;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; LONG TERM CARE; MALE; PANCREAS ISLET TRANSPLANTATION; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REVIEW; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME; ARTICLE; DOSE RESPONSE; HEALTH STATUS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY;

ADULT; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEPTIDES; QUALITY OF LIFE; RETROSPECTIVE STUDIES; VENOMS;

EID: 58149147499     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818a7f45     Document Type: Review

References (20)

1. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
2. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
3. Ricordi C. Islet transplantation: A brave new world. Diabetes 2003; 52: 1595.
4. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 Diabetes mellitus using cultured islets and steroid-free immunosup-pression: Miami experience. Am J Transplant 2005; 5: 2037.
5. Poggioli R, Faradji RN, Ponte G, et al. Quality of life after islet transplantation. Am J Transplant 2006; 6: 371.
6. Toso C, Shapiro AM, Bowker S, et al. Quality of life after islet transplant: Impact of the number of islet infusions and metabolic outcome. Transplantation 2007; 84: 664.
7. Barshes NR, Vanatta JM, Mote A, et al. Health-related quality of life after pancreatic islet transplantation: A longitudinal study. Transplantation 2005; 79: 1727.
8. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001; 357: 7.
9. Jacobson AM, de Groot M, Samson JA. The evaluationof two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17: 267.
10. Jacobson AM; the DCCT research group. The Diabetes quality of life measure. In: Bradley C, ed. Handbook of psychology and diabetes: A guide to psychological measurement in diabetes. Harwood, Chur, 1994: 65.
11. Cure P, Pileggi A, Froud T, et al. Improved metabolic control and quality of life in seven patients with type 1 Diabetes following islet after kidney transplantation. Transplantation 2008; 85: 801.
12. Froud T, Faradji RN, Pileggi A, et al. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: Safety, efficacy and metabolic effects. Transplantation 2008; 86: 36.
13. Mineo D, Ricordi C, Xu X, et al. Combined islet and hematopoietic stem cell allotransplantation: A clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant 2008; 8: 1262.
14. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989; 262: 907.
15. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care 1988;11: 725.
16. Reoffrey RN, David LS. Screwups, oddballs, and other vagaries of science. Locating outliers, handling missing data, and transformations. In: Geoffrey RN, David LS, eds. Biostatistics. Hamilton, BC Decker Inc 2008, pp 302.
17. Zhang X, Norris SL, Chowdhury FM, et al. The effects of interventions on health-related qualityof life among persons with diabetes:Asystem-atic review. Med Care 2007; 45: 820.
18. Influence of intensive diabetes treatment on quality-of-life outcomes in the Diabetes control and complications trial. Diabetes Care 1996; 19: 195.
19. Hoey H, Aanstoot HJ, Chiarelli F, et al. Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care 2001; 24: 1923.
20. Guttmann-Bauman I, Flaherty BP, Strugger M, et al. Metabolic control and quality-of-life self-assessment in adolescents with IDDM. Diabetes Care 1998; 21: 915.